Home > EMCDDA–Europol joint report on a new psychoactive substance: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (‘MT-45’).

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2014) EMCDDA–Europol joint report on a new psychoactive substance: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (‘MT-45’). Luxembourg: Publications Office of the European Union.

[img]
Preview
PDF (EMCDDA–Europol Joint Report on ‘MT-45’)
358kB

In April 2014, the EMCDDA and Europol examined the available information on a new psychoactive substance 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine, commonly known as MT-45. The two organisations concluded that sufficient information had been accumulated to merit the production of a Joint Report on MT-45 as stipulated by Article 5.1 of the Council Decision.

Table of contents:
• Introduction
• Information collection process
• Information required by Article 5.2 of the Council Decision
• Information from the EMA (Article 5.3 of the Council Decision)
• Conclusion
• References
• Annexes


Date:2014
Pages:17 p.
Publisher:Publications Office of the European Union
Corporate Creators:European Monitoring Centre for Drugs and Drug Addiction, Europol
Place of Publication:Luxembourg
ISBN:978-92-9168-745-9
EndNote:View
Accession Number:HRB (Electronic Only)
Subjects:B Drugs and alcohol substances > New (novel) psychoactive substances
VA Geographic area > Europe

Repository Staff Only: item control page